Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)

INTRODUCTION: This study evaluated various remission criteria in abatacept plus methotrexate (MTX)-treated patients with early rheumatoid arthritis (RA). We aimed to investigate the time to, and sustainability of, remission, and to evaluate the relationship between remission, function and structure....

Descripción completa

Detalles Bibliográficos
Autores principales: Smolen, Josef S., Wollenhaupt, Jürgen, Gomez-Reino, Juan J., Grassi, Walter, Gaillez, Corine, Poncet, Coralie, Le Bars, Manuela, Westhovens, Rene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494702/
https://www.ncbi.nlm.nih.gov/pubmed/26063454
http://dx.doi.org/10.1186/s13075-015-0671-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494702/
https://www.ncbi.nlm.nih.gov/pubmed/26063454
http://dx.doi.org/10.1186/s13075-015-0671-9

Ejemplares similares